ArticleZhongguo fei ai za zhi = Chinese journal of lung cancer2017
[China Experts Consensus on the Diagnosis and Treatment of Brain Metastases of Lung Cancer (2017 version)].
Abstract readConsensus Statement
In one paragraph
Article in Zhongguo fei ai za zhi = Chinese journal of lung cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first-line treatment for Chinese patients with unresectable, metastatic, or recurrent non-squamous non-small-cell lung cancer: A multicenter, randomized, double-blinded, phase III trial.Cancer communications (London, England) · 2021Trial
- Epidermal growth factor receptor tyrosine kinase inhibitor for the treatment of non-small cell lung cancer in the past 30 years (1997-2026).Chinese medical journal · 2026Review
- Brain radiotherapy combined with immune checkpoint inhibitors and chemotherapy as first-line treatment for advanced non-small cell lung cancer with brain metastases: a retrospective study.BMC immunology · 2026Article
- Breast cancer brain metastasis: mechanisms, emerging biomarkers, and therapeutic opportunities.American journal of cancer research · 2026Review
- MRI quantitative imaging biomarkers in differentiating brain parenchymal tuberculoma and lung cancer brain metastases.European journal of medical research · 2025Article
- [Research Progress on the Mechanism of Gut Microbiota Influencing Lung Cancer Brain Metastasis via the Brain-gut Axis].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2025Review
- Cost-effectiveness analysis of first-line gifitinib plus pemetrexed-platinum-based chemotherapy versus gifitinib monotherapy in EGFR-mutated NSCLC patients with brain metastases.BMC health services research · 2025Article
- Intrathecal pemetrexed chemotherapy combined with systemic therapy in patients with non-small cell lung cancer and leptomeningeal metastases: a retrospective study.Frontiers in oncology · 2025Review
- Double-dose osimertinib combined with intrathecal injection of pemetrexed improves the efficacy of EGFR-mutant non-small cell lung cancer and leptomeningeal metastasis: case report and literature review.Frontiers in oncology · 2024Article
- CD146 promotes resistance of NSCLC brain metastases to pemetrexed via the NF-κB signaling pathway.Frontiers in pharmacology · 2024Article
- Warburg effect enhanced by AKR1B10 promotes acquired resistance to pemetrexed in lung cancer-derived brain metastasis.Journal of translational medicine · 2023Article
- The diagnostic significance of cerebrospinal fluid cytology and circulating tumor DNA in meningeal carcinomatosis.Frontiers in neurology · 2023Article
- Serum neurofilament light chain or glial fibrillary acidic protein in the diagnosis and prognosis of brain metastases.Journal of neurology · 2022Article
- Review
- Glutathione peroxidase 4-dependent glutathione high-consumption drives acquired platinum chemoresistance in lung cancer-derived brain metastasis.Clinical and translational medicine · 2021Article
- The changing landscape of anti-lung cancer drug clinical trials in mainland China from 2005 to 2020.The Lancet regional health. Western Pacific · 2021Article
- Treatment and Prognosis of Solid and Cystic Brain Metastases in Patients with Non-Small-Cell Lung Cancer.Cancer management and research · 2021Article
- [Research Progress in the Treatment of Brain Metastases from Non-small Cell Lung Cancer].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2020Review
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
50 authors.
Yuankai ShiNational Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, 100021 Beijing, China.
Yan SunNational Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, 100021 Beijing, China.
Jinming YuShandong Province Cancer Hospital, 250117 Jinan, China.
Cuimin DingThe Fourth Hospital of Hebei Medical University, 050000 Shijiazhuang, China.
Zhiyong MaHenan Province Cancer Hospital, 450008 Zhengzhou, China.
Ziping WangBeijing Cancer Hospital, 100142 Beijing, China.
Dong WangDaping Hospital, Third Military Medical University, 400042 Chongqing, China.
Zheng WangNational Center for Geriatric Medicine/Beijing Hospital, 100730 Beijing, China.
Mengzhao WangPeking Union Medical College Hospital, 100730 Beijing, China.
Yan WangNational Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, 100021 Beijing, China.
You LuWest China Hospital of Sichuan University, 610041 Chengdu, China.
Bin AiNational Center for Geriatric Medicine/Beijing Hospital, 100730 Beijing, China.
Jifeng FengJiangsu Cancer Hospital, 210009 Nanjing, China.
Yunpeng LiuThe First Hospital of China Medical University, 110001 Shenyang, China.
Xiaoqing LiuThe 307th Hospital of Chinese People's Liberation Army, 100071 Beijing, China.
Jiwei LiuThe First Affiliated Hospital of Dalian Medical University, 116011 Dalian, China.
Gang WuHuazhong University of Science and Technology Union Hospital, 430022 Wuhan, China.
Baolin QuChinese People's Liberation Army General Hospital, 100853 Beijing, China.
Xueji LiNational Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 100021 Beijing, China.
Enxiao LiThe First Affiliated Hospital of Xi 'an Jiaotong University, 710061 Xi'an, China.
Wei LiThe First Hospital of Jilin University, 130021 Changchun, China.
Yong SongNanjing General Hospital, 210002 Nanjing, China.
Gongyan ChenHarbin Medical University Cancer Hospital, 150081 Harbin, China.
Zhengtang ChenXinqiao Hospital of Third Military medical University, 400037 Chongqing, China.
Jun ChenThe Second Hospital of Dalian Medical University, 116027 Dalian, China.
Ping YuSichuan Cancer Hospital, 610047 Chengdu, China.
Ning WuNational Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 100021 Beijing, China.
Milu WuQinghai University Affiliated Cancer Hospital, 810000 Xining, China.
Wenhua XiaoThe First Affiliated Hospital of Chinese People's Liberation Army General Hospital, 100048 Beijing, China.
Jianping XiaoNational Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 100021 Beijing, China.
Li ZhangPeking Union Medical College Hospital, 100730 Beijing, China.
Yang ZhangThe Second Hospital of Dalian Medical University, 116027 Dalian, China.
Yiping ZhangZhejiang Cancer Hospital, 310022 Hangzhou, China.
Shucai ZhangBeijing Chest Hospital, Capital Medical University, 101149 Beijing, China.
Xia SongShanxi Province Cancer Hospital, 030013 Taiyuan, China.
Rongcheng LuoTCM-Integrated Cancer Center of Southern Medical University, 510315 Guangzhou, China.
Caicun ZhouTongji University Affiliated Shanghai Pulmonary Hospital, 200433 Shanghai, China.
Zongmei ZhouNational Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 100021 Beijing, China.
Qiong ZhaoThe First Affiliated Hospital, Zhejiang University, 310003 Hangzhou, China.
Chengping HuXiangya Hospital Central South University, 410008 Changsha, China.
Yi HuChinese People's Liberation Army General Hospital, 100853 Beijing, China.
Ligong NiePeking University First Hospital, 100034 Beijing, China.
Qisen GuoThe Fourth Hospital of Hebei Medical University, 050000 Shijiazhuang, China.
Jianhua ChangFudan Universitay Shanghai Cancer Center, 200032 Shanghai, China.
Cheng HuangFujian Cancer Hospital, 350014 Fuzhou, China.
Baohui HanShanghai Chest Hospital, Shanghai Jiaotong University, 200030 Shanghai, China.
Xiaohong HanNational Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, 100021 Beijing, China.
Gong LiGeneral Hospital of Armed Police, 100039 Beijing, China.
Yu HuangNational Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, 100021 Beijing, China.
Youwu ShiNational Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, 100021 Beijing, China.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
ConsensusBrain NeoplasmsChinaHumansLung Neoplasms
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.